Table 1.
Baseline characteristics of the participants
| Characteristic | Intervention(n = 30) | Control(n = 30) | P |
|---|---|---|---|
| Age, years | 52±9 | 52±10 | 0.80 |
| Sex, % | |||
| Female | 29 (97%) | 29 (97%) | 0.99 |
| Male | 1 (3%) | 1 (3%) | |
| Race, % | |||
| White | 26 (87%) | 26 (87%) | 0.99 |
| Black | 2 (7%) | 1 (3%) | |
| Other | 2 (7%) | 3 (10%) | |
| Education, % | |||
| High School or Less | 1 (3%) | 4 (13%) | 0.54 |
| Some College | 5 (17%) | 5 (17%) | |
| College Degree or More | 24 (80%) | 21 (70%) | |
| Body Mass Index, kg/m2 | 32.1±5.6 | 31.5±5.3 | 0.67 |
| Cancer Type, % | |||
| Breast | 24 (80%) | 22 (73%) | 0.25 |
| Gynecologic | 0 (0%) | 4 (13%) | |
| Hematologic | 2 (7%) | 2 (7%) | |
| Genitourinary | 1 (3%) | 1 (3%) | |
| Gastrointestinal | 1 (3%) | 1 (3%) | |
| Sarcoma | 2 (7%) | 0 (0%) | |
| Time Since Diagnosis, mo. | 39.1±31.0 | 41.1±38.9 | 0.95 |
| Cancer Treatment, % | |||
| Chemotherapy | 19 (63%) | 21 (70%) | 0.58 |
| Radiation | 22 (73%) | 18 (60%) | 0.41 |
| Hormone | 20 (67%) | 22 (73%) | 0.57 |